A 35-year-old man is admitted to the ICU with a diagnosis of toxic epidermal necrolysis (TEN). He developed the condition 8 days after starting phenytoin for newly diagnosed seizures. On admission, he has fever (39.2°C), widespread blistering and skin necrosis involving 35% of body surface area, and involvement of oral, ocular, and genital mucosa. His blood cultures are pending. Serum creatinine is 1.8 mg/dL (baseline 0.9), and he has mild transaminitis. What is the most important prognostic factor that should guide the intensity of his management?

Explanation

## Prognostic Assessment in Toxic Epidermal Necrolysis (TEN) ### Definition and Severity **Key Point:** TEN is defined as SJS with ≥30% body surface area (BSA) involvement. This patient has 35% BSA involvement, placing him in the TEN category with significantly higher mortality (25–50%) compared to SJS (1–5%). ### SCORTEN Score: The Gold Standard Prognostic Tool **High-Yield:** The SCORTEN score is the most validated prognostic tool in TEN and should guide intensity of management. It is calculated at admission and reassessed at day 3. | SCORTEN Variable | Points | |------------------|--------| | Age > 40 years | 1 | | Heart rate > 120/min | 1 | | Serum urea > 10 mmol/L (28 mg/dL) | 1 | | Serum glucose > 14 mmol/L (252 mg/dL) | 1 | | Serum bicarbonate < 20 mEq/L | 1 | | BSA detached on day 1 > 10% | 1 | **Clinical Pearl:** This patient has: - Age 35 (no point) - Renal impairment (Cr 1.8, suggesting elevated urea — likely 1 point) - 35% BSA involvement (1 point) - Possible metabolic derangement (need to assess HCO~3~, glucose) Even with a moderate SCORTEN score, the combination of **high BSA involvement (35%) and systemic organ involvement (renal impairment, hepatic transaminitis)** indicates severe disease requiring maximal supportive care and immunomodulatory therapy. ### Mortality Risk by SCORTEN Score | SCORTEN | Mortality Risk | |---------|----------------| | 0–1 | 3.2% | | 2 | 12.1% | | 3 | 35.3% | | 4 | 58.3% | | ≥ 5 | > 90% | ### Why BSA and Systemic Involvement Are Paramount **Key Point:** The extent of skin necrosis (BSA) directly correlates with: 1. **Fluid and electrolyte loss** — similar to burn injury 2. **Infection risk** — loss of skin barrier 3. **Multi-organ dysfunction** — systemic inflammatory response This patient's renal impairment (Cr 1.8) and hepatic involvement (transaminitis) indicate **systemic organ involvement**, which is a strong independent predictor of mortality and should drive aggressive management (IVIG, high-dose corticosteroids, specialized ICU care). ### Management Algorithm Based on Severity ```mermaid flowchart TD A[TEN Diagnosis: BSA ≥ 30%]:::outcome --> B[Calculate SCORTEN Score]:::action B --> C{SCORTEN Score?}:::decision C -->|0-1| D[Low Risk: Supportive Care]:::action C -->|2-3| E[Moderate Risk: Supportive + IVIG/Corticosteroids]:::action C -->|≥4| F[High Risk: Maximal Therapy]:::urgent F --> G1[IVIG 2 g/kg over 3-5 days] F --> G2[High-dose IV Corticosteroids] F --> G3[ICU Monitoring] F --> G4[Aggressive Fluid Management] E --> H[Monitor Organ Function] D --> H H --> I{Deterioration?}:::decision I -->|Yes| J[Escalate to High-Risk Protocol]:::urgent I -->|No| K[Continue Current Regimen]:::action ``` ### Why Systemic Organ Involvement Matters **Clinical Pearl:** The presence of renal impairment (Cr 1.8) and hepatic transaminitis in this patient indicates that TEN is not merely a dermatologic emergency — it is a **multi-system inflammatory crisis**. Organ involvement drives mortality and mandates: - Aggressive fluid resuscitation (similar to burn management) - Close monitoring of electrolytes, renal function, and hepatic function - Early consideration of IVIG and/or high-dose corticosteroids - ICU-level care with specialized nursing **Mnemonic: ORGAN in TEN — Outcome Reflects Generalized Acute Necrosis** [cite:Robbins 10e Ch 25; Harrison 21e Ch 56]